Exhibit 99.2
Press Release www.shire.com |  |
Director/PDMR Shareholding
December 20, 2017 – Shire plc (LSE: SHP, NASDAQ: SHPG)
Notification of transactions by persons discharging managerial responsibilities
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) |
| a) | Name | Susan Kilsby |
| 2. | Reason for the notification |
| a) | Position / status | Chairman – PDMR |
| b) | Initial notification / amendment | Initial notification |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor |
| a) | Name | Shire plc |
| b) | LEI | 54930005LQRLI2UXRQ59 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) |
| Identification code | ISIN: US82481R1068 |
| b) | Nature of the transaction | Acquisition of ADSs, being the part of Ms. Kilsby’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2017. |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $155.9200 | 178 |
| d) | Aggregated information - Aggregated volume - Price | N/A (single transaction) |
| e) | Date of the transaction | December 19, 2017 |
| f) | Place of the transaction | EDGX |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) |
| a) | Name | William Burns |
| 2. | Reason for the notification |
| a) | Position / status | Senior Independent Director - PDMR |
| b) | Initial notification / amendment | Initial notification |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor |
| a) | Name | Shire plc |
| b) | LEI | 54930005LQRLI2UXRQ59 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) | Description of the financial instrument, type of instrument | Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”) |
| Identification code | ISIN: JE00B2QKY057 |
| b) | Nature of the transaction | Acquisition of Ordinary Shares, being the part of Mr. Burns’ total fees that are paid in Ordinary Shares for the period of service from October 1 to December 31, 2017. |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| See appendix below |
| d) | Aggregated information - Aggregated volume - Price | Weighted average price | Volume |
| £37.8950 | 180 |
| e) | Date of the transaction | December 19, 2017 |
| f) | Place of the transaction | XLON / BATE / CHIX / TRQX |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) |
| a) | Name | Dominic Blakemore |
| 2. | Reason for the notification |
| a) | Position / status | Non-Executive Director – PDMR |
| b) | Initial notification / amendment | Initial notification |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor |
| a) | Name | Shire plc |
| b) | LEI | 54930005LQRLI2UXRQ59 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) | Description of the financial instrument, type of instrument | Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”) |
| Identification code | ISIN: JE00B2QKY057 |
| b) | Nature of the transaction | Acquisition of Ordinary Shares, being the part of Mr. Blakemore’s total fees that are paid in Ordinary Shares for the period of service from October 1 to December 31, 2017. |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| See appendix below |
| d) | Aggregated information - Aggregated volume - Price | Weighted average price | Volume |
| £37.8950 | 165 |
| e) | Date of the transaction | December 19, 2017 |
| f) | Place of the transaction | XLON / BATE / CHIX / TRQX |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) |
| a) | Name | Olivier Bohuon |
| 2. | Reason for the notification |
| a) | Position / status | Non-Executive Director - PDMR |
| b) | Initial notification / amendment | Initial notification |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor |
| a) | Name | Shire plc |
| b) | LEI | 54930005LQRLI2UXRQ59 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) | Description of the financial instrument, type of instrument | Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”) |
| Identification code | ISIN: JE00B2QKY057 |
| b) | Nature of the transaction | Acquisition of Ordinary Shares, being the part of Mr. Bohuon’s total fees that are paid in Ordinary Shares for the period of service from October 1 to December 31, 2017. |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| See appendix below |
| d) | Aggregated information - Aggregated volume - Price | Weighted average price | Volume |
| £37.8950 | 161 |
| e) | Date of the transaction | December 19, 2017 |
| f) | Place of the transaction | XLON / BATE / CHIX / TRQX |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) |
| a) | Name | Ian Clark |
| 2. | Reason for the notification |
| a) | Position / status | Non-Executive Director - PDMR |
| b) | Initial notification / amendment | Initial notification |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor |
| a) | Name | Shire plc |
| b) | LEI | 54930005LQRLI2UXRQ59 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) |
| Identification code | ISIN: US82481R1068 |
| b) | Nature of the transaction | Acquisition of ADSs, being the part of Mr. Clark’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2017. |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $155.9200 | 67 |
| d) | Aggregated information - Aggregated volume - Price | N/A (single transaction) |
| e) | Date of the transaction | December 19, 2017 |
| f) | Place of the transaction | EDGX |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) |
| a) | Name | Gail Fosler |
| 2. | Reason for the notification |
| a) | Position / status | Non-Executive Director - PDMR |
| b) | Initial notification / amendment | Initial notification |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor |
| a) | Name | Shire plc |
| b) | LEI | 54930005LQRLI2UXRQ59 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) |
| Identification code | ISIN: US82481R1068 |
| b) | Nature of the transaction | Acquisition of ADSs, being the part of Ms. Fosler’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2017. |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $155.9200 | 48 |
| d) | Aggregated information - Aggregated volume - Price | N/A (single transaction) |
| e) | Date of the transaction | December 19, 2017 |
| f) | Place of the transaction | EDGX |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) |
| a) | Name | Steven Gillis |
| 2. | Reason for the notification |
| a) | Position / status | Non-Executive Director - PDMR |
| b) | Initial notification / amendment | Initial notification |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor |
| a) | Name | Shire plc |
| b) | LEI | 54930005LQRLI2UXRQ59 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) |
| Identification code | ISIN: US82481R1068 |
| b) | Nature of the transaction | Acquisition of ADSs, being the part of Dr. Gillis’ total fees that are paid in ADSs for the period of service from October 1 to December 31, 2017. |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $155.9200 | 59 |
| d) | Aggregated information - Aggregated volume - Price | N/A (single transaction) |
| e) | Date of the transaction | December 19, 2017 |
| f) | Place of the transaction | EDGX |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) |
| a) | Name | David Ginsburg |
| 2. | Reason for the notification |
| a) | Position / status | Non-Executive Director - PDMR |
| b) | Initial notification / amendment | Initial notification |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor |
| a) | Name | Shire plc |
| b) | LEI | 54930005LQRLI2UXRQ59 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) |
| Identification code | ISIN: US82481R1068 |
| b) | Nature of the transaction | Acquisition of ADSs, being the part of Dr. Ginsburg’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2017. |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $155.9200 | 50 |
| d) | Aggregated information - Aggregated volume - Price | N/A (single transaction) |
| e) | Date of the transaction | December 19, 2017 |
| f) | Place of the transaction | EDGX |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) |
| a) | Name | Sara Mathew |
| 2. | Reason for the notification |
| a) | Position / status | Non-Executive Director - PDMR |
| b) | Initial notification / amendment | Initial notification |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor |
| a) | Name | Shire plc |
| b) | LEI | 54930005LQRLI2UXRQ59 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) |
| Identification code | ISIN: US82481R1068 |
| b) | Nature of the transaction | Acquisition of ADSs, being the part of Ms. Mathew’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2017. |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $155.9200 | 56 |
| d) | Aggregated information - Aggregated volume - Price | N/A (single transaction) |
| e) | Date of the transaction | December 19, 2017 |
| f) | Place of the transaction | EDGX |
1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) |
| a) | Name | Anne Minto |
| 2. | Reason for the notification |
| a) | Position / status | Non-Executive Director - PDMR |
| b) | Initial notification / amendment | Initial notification |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor |
| a) | Name | Shire plc |
| b) | LEI | 54930005LQRLI2UXRQ59 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) | Description of the financial instrument, type of instrument | Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”) |
| Identification code | ISIN: JE00B2QKY057 |
| b) | Nature of the transaction | Acquisition of Ordinary Shares, being the part of Ms. Minto’s total fees that are paid in Ordinary Shares for the period of service from October 1 to December 31, 2017. |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| See appendix below |
| d) | Aggregated information - Aggregated volume - Price | Weighted average price | Volume |
| £37.8950 | 182 |
| e) | Date of the transaction | December 19, 2017 |
| f) | Place of the transaction | XLON / BATE / CHIX / TRQX |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) |
| a) | Name | Albert Stroucken |
| 2. | Reason for the notification |
| a) | Position / status | Non-Executive Director - PDMR |
| b) | Initial notification / amendment | Initial notification |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor |
| a) | Name | Shire plc |
| b) | LEI | 54930005LQRLI2UXRQ59 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) |
| Identification code | ISIN: US82481R1068 |
| b) | Nature of the transaction | Acquisition of ADSs, being the part of Mr. Stroucken’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2017. |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $155.9200 | 64 |
| d) | Aggregated information - Aggregated volume - Price | N/A (single transaction) |
| e) | Date of the transaction | December 19, 2017 |
| f) | Place of the transaction | EDGX |
Appendix: individual / aggregated transaction details for PDMRs
| Shire plc Ordinary Shares of 5 pence each |
| Place of the transaction | Price(s) | Volume(s) |
| XLON | £37.8850 | 15 |
| XLON | £37.8850 | 43 |
| XLON | £37.8850 | 71 |
| XLON | £37.9000 | 194 |
| XLON | £37.9000 | 265 |
| BATE | £37.8850 | 36 |
| CHIX | £37.8850 | 9 |
| CHIX | £37.8850 | 37 |
| TRQX | £37.8850 | 1 |
| TRQX | £37.8850 | 17 |
| | | |
| Place of the transaction | Weighted average price | Aggregated volume |
| XLON | £37.8967 | 588 |
| BATE | £37.8850 | 36 |
| CHIX | £37.8850 | 46 |
| TRQX | £37.8850 | 18 |
| | | |
| Total | £37.8950 | 688 |
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
| Investor Relations | | |
| Ian Karp | ikarp@shire.com | +1 781 482 9018 |
| Robert Coates | rcoates@shire.com | +44 1256 894874 |
| Media | | |
| Lisa Adler | lisa.adler@shire.com | +1 617 588 8607 |
| Katie Joyce | kjoyce@shire.com | +1 781 482 2779 |
NOTES TO EDITORS
About Shire
Shire is the leading global biotechnology company focused on serving people with rare diseases. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.
Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.
www.shire.com
